Iodine-125 brachytherapy for prostate cancer: first published Australian experience

Australasian Radiology
D J JosephA Haworth

Abstract

With the emergence of new imaging and implant techniques, prostate brachytherapy has become increasingly popular over the last decade. Brachytherapy promises to deliver twice the biologically effective dose as conventional external beam treatments without increasing the dose to tissues surrounding the prostate. However, there are few or no published Australian series of its efficacy in the clinic. We present the experience of one of the first centres in Australia to offer this service to its patients: a series from Sir Charles Gairdner Hospital in Western Australia. We present data on the efficacy of brachytherapy in maintaining prostate specific antigen levels, as well as the rate of urinary, rectal and sexual complications. Our results compare favourably with other brachytherapy and external beam treatment series. We believe that with the increasing trend towards dose escalation and novel therapies, standardized measurements of success and failure need to be better defined, and that randomized trials comparing modalities are needed to improve the management of prostate cancer.

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·G K Zagars
Aug 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A RitterT J Kinsella
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·E M SoffenB E Epstein
Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
May 15, 1995·International Journal of Radiation Oncology, Biology, Physics·B W CornL R Coia
Jun 1, 1996·Hematology/oncology Clinics of North America·P D GrimmD Clarke
Jul 4, 1998·International Journal of Radiation Oncology, Biology, Physics·M J ZelefskyZ Fuks
Jul 1, 1999·International Journal of Radiation Oncology, Biology, Physics·S NagR Nath
Aug 24, 2000·American Journal of Clinical Oncology·R B WilderR D White
Jan 9, 2001·CA: a Cancer Journal for Clinicians·H RagdeA A Elgamal
May 23, 2002·International Journal of Radiation Oncology, Biology, Physics·Alvaro A MartinezFrank Vicini

❮ Previous
Next ❯

Citations

Jan 13, 2006·Prostate Cancer and Prostatic Diseases·V BhatnagarR M Kaplan
Mar 30, 2016·Journal of Medical Imaging and Radiation Oncology·Craig WilsonDavid Joseph

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Australian Journal of Advanced Nursing : a Quarterly Publication of the Royal Australian Nursing Federation
R C MacKayK Matsuno
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
Clodagh A M PowerBrigit Roberts
The Australian and New Zealand Journal of Surgery
R L InsallA K House
© 2022 Meta ULC. All rights reserved